Batch review
Explore where connected records may help qualified reviewers identify exceptions, missing evidence, and recurring patterns.
Technology with accountable oversight
Better access to evidence. Experienced judgment remains essential.
TailwindAI
Advisory partner for organizations evaluating Litewave
Evaluate AI for quality and manufacturing through a regulatory lens.
Tailwind Pharma helps pharmaceutical leaders determine where Litewave may support GMP work, what evidence and controls matter, and whether the organization is ready for governed adoption.
The starting point is not the technology. It is the quality decision, the supporting records, and the people accountable for the outcome.
01 · The opportunity
The evidence behind GMP decisions rarely lives in one place.
Batch records, deviations, CAPAs, laboratory results, procedures, supplier files, and prior decisions often sit across different systems—and sometimes on paper.
Litewave is developing technology intended to connect that evidence for quality and manufacturing work. Tailwind Pharma helps leaders evaluate where that approach may fit, which limitations matter, and how the use case could stand up to internal and regulatory scrutiny.
The value is not simply finding information faster. It is making the evidence behind a quality decision easier to examine and trace.
02 · Where it may help
Practical use cases worth examining
These are areas for careful evaluation—not promises of automated decisions or validated performance.
Investigation support
Bring prior events, procedures, CAPAs, and source records into view so investigation teams can test hypotheses against broader evidence.
Supplier and CDMO oversight
Consider how evidence across partners, sites, and systems may support more consistent sponsor oversight and escalation.
Quality-system intelligence
Examine practical ways to connect paper and digital records while preserving context, attribution, and review history.
Quality trend analysis
Define risk-based views that may help experienced teams recognize recurring signals without surrendering decision authority.
03 · Tailwind advisory approach
Begin with the decision. Then evaluate the technology.
Tailwind helps connect the operational opportunity to the controls, responsibilities, and regulatory questions that must accompany it.
Assess the use case
Start with the quality decision, evidence gap, or oversight problem—not the technology.
Define controls
Identify source records, review responsibilities, traceability needs, and decision boundaries.
Evaluate readiness
Examine data quality, workflows, validation expectations, governance, and operational fit.
Support adoption
Help leadership establish a defensible path from evaluation through governed implementation.
FDA field investigation, CDER compliance, and corporate quality leadership
04 · Why Tailwind Pharma
Technology decisions informed by regulatory and operating experience
Tailwind Pharma brings firsthand experience across FDA field investigations, CDER compliance decision-making, and global pharmaceutical quality leadership to the evaluation of emerging quality technology.
That perspective helps leadership pressure-test the intended use, identify weaknesses before deployment, and establish clear boundaries between technological assistance and regulated accountability.
Traceability from an output back to the supporting source evidence
Risk-based validation planning appropriate to intended use
Documented human review, escalation, and approval responsibilities
Data-integrity controls aligned with ALCOA+ expectations
Clear accountability for the manufacturer's designated Quality Unit
Considering Litewave?
Evaluate the use case before committing to implementation.
Discuss the records, workflow, oversight challenge, and regulatory context with Tailwind Pharma.
Litewave is a separate technology company. Tailwind Pharma provides advisory support and does not represent that any system is validated for a particular intended use. AI does not replace the manufacturer’s Quality Unit, validation responsibilities, professional judgment, or regulatory accountability.